Other Species / Isoforms
  NKX2-1 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
-
gap
0 4
NKX2-1 (human) gap -
NKX2-1 iso3 (human) SGGSGKArGWEAAAG R10-m1
NKX2-1 (mouse) gap -
NKX2-1 (rat) gap -
S4
____MSMSPKHTtPF
0 1
NKX2-1 (human) ____MSMSPKHTTPF S4
NKX2-1 iso3 (human) RRRIMSMSPKHTTPF S34
NKX2-1 (mouse) ____MSMsPKHTTPF S4-p
NKX2-1 (rat) ____MSMSPKHTtPF S4
T9-p
SMSPKHTtPFsVSDI
Upstream
Downstream
2 0
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • PKACA (rat)
  • PKACB (mouse)
Putative in vivo kinases:
  • PKACB (mouse)
NKX2-1 (human) SMSPKHTTPFSVSDI T9
NKX2-1 iso3 (human) SMSPKHTTPFSVSDI T39
NKX2-1 (mouse) SMsPKHTTPFSVSDI T9
NKX2-1 (rat) SMSPKHTtPFsVSDI T9-p
S12-p
PKHTtPFsVSDILsP
1 0
NKX2-1 (human) PKHTTPFSVSDILSP S12
NKX2-1 iso3 (human) PKHTTPFSVSDILSP S42
NKX2-1 (mouse) PKHTTPFSVSDILSP S12
NKX2-1 (rat) PKHTtPFsVSDILsP S12-p
S18-p
FsVSDILsPLEEsYK
1 0
NKX2-1 (human) FSVSDILSPLEEsYK S18
NKX2-1 iso3 (human) FSVSDILSPLEESYK S48
NKX2-1 (mouse) FSVSDILSPLEESYK S18
NKX2-1 (rat) FsVSDILsPLEEsYK S18-p
S23-p
ILsPLEEsYKKVGME
1 1
NKX2-1 (human) ILSPLEEsYKKVGME S23-p
NKX2-1 iso3 (human) ILSPLEESYKKVGME S53
NKX2-1 (mouse) ILSPLEESYKKVGME S23
NKX2-1 (rat) ILsPLEEsYKKVGME S23-p
A50
QGQAAPPAAAMQQHA
0 1
NKX2-1 (human) QGQAAPPtAAMQQHA T50-p
NKX2-1 iso3 (human) QGQAAPPTAAMQQHA T80
NKX2-1 (mouse) QGQAAPPAAAMQQHA A50
NKX2-1 (rat) QGQAAPPAAAMQQHA A50
Y114
SASGPGWYGANPDPR
0 1
NKX2-1 (human) SASGPGWyGANPDPr Y114-p
NKX2-1 iso3 (human) SASGPGWYGANPDPR Y144
NKX2-1 (mouse) SASGPGWYGANPDPR Y114
NKX2-1 (rat) SASGPGWYGANPDPR Y114
R121
YGANPDPRFPAISRF
0 12
NKX2-1 (human) yGANPDPrFPAISrF R121-m1
NKX2-1 iso3 (human) YGANPDPRFPAISRF R151
NKX2-1 (mouse) YGANPDPRFPAISRF R121
NKX2-1 (rat) YGANPDPRFPAISRF R121
R121
YGANPDPRFPAISRF
0 1
NKX2-1 (human) yGANPDPrFPAISrF R121-m2
NKX2-1 iso3 (human) YGANPDPRFPAISRF R151
NKX2-1 (mouse) YGANPDPRFPAISRF R121
NKX2-1 (rat) YGANPDPRFPAISRF R121
R127
PRFPAISRFMGPASG
0 8
NKX2-1 (human) PrFPAISrFMGPASG R127-m1
NKX2-1 iso3 (human) PRFPAISRFMGPASG R157
NKX2-1 (mouse) PRFPAISRFMGPASG R127
NKX2-1 (rat) PRFPAISRFMGPASG R127
S255-p
QQQAQQQsPRRVAVP
Upstream
1 4
Treatment
  • colforsin
NKX2-1 (human) QQQAQQQsPRRVAVP S254-p
NKX2-1 iso3 (human) QQQAQQQSPRRVAVP S284
NKX2-1 (mouse) QQQAQQQSPRRVAVP S255
NKX2-1 (rat) QQQAQQQsPRRVAVP S255-p
S328-p
QPGSAGQsPDLAHHA
Upstream
1 0
NKX2-1 (human)
S327-p
NKX2-1 (mouse)
S328-p
NKX2-1 (rat)
S328-p
Treatment
  • colforsin
NKX2-1 (human) QPGSAGQSPDLAHHA S327
NKX2-1 iso3 (human) QPGSAGQSPDLAHHA S357
NKX2-1 (mouse) QPGSAGQSPDLAHHA S328
NKX2-1 (rat) QPGSAGQsPDLAHHA S328-p
S337-p
DLAHHAAsPAALQGQ
Upstream
1 0
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • colforsin
NKX2-1 (human) DLAHHAASPAALQGQ S336
NKX2-1 iso3 (human) DLAHHAASPAALQGQ S366
NKX2-1 (mouse) DLAHHAASPAGLQGQ S337
NKX2-1 (rat) DLAHHAAsPAALQGQ S337-p